Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Citron

Showing results (41-50 of 590) with videos related to

Pageof 59
Sort By:
Clinical Therapeutics|January 1, 1988
Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteriaE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|January 1, 1986
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitalsE J Goldstein, D M Citron
New York State Journal of Medicine|April 1, 1990
Tumor metastasis to an infusaport siteR Zelnick, M Citron, E Munoz
Antimicrobial Agents and Chemotherapy|May 1, 1993
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agentsE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|April 1, 1985
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitalsE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|February 1, 1985
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitalsE J Goldstein, D M Citron
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
How far should a clinical laboratory go in identifying anaerobic isolates, and who should pay?D M Citron, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 23, 1997
Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infectionsD M Citron, M D Appleman
Journal of Clinical Microbiology|November 1, 1988
Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis groupE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|December 20, 2000
Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteriaD M Citron, M D Appleman
Pageof 59

Showing results (41-50 of 590) with videos related to

Sort By:
Pageof 59
Clinical Therapeutics|January 1, 1988
Comparative in vitro activity of imipenem and 15 other antimicrobial agents against clinically important aerobic and anaerobic bacteriaE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|January 1, 1986
Comparative in vitro activities of amoxicillin-clavulanic acid and imipenem against anaerobic bacteria isolated from community hospitalsE J Goldstein, D M Citron
New York State Journal of Medicine|April 1, 1990
Tumor metastasis to an infusaport siteR Zelnick, M Citron, E Munoz
Antimicrobial Agents and Chemotherapy|May 1, 1993
Comparative susceptibilities of 173 aerobic and anaerobic bite wound isolates to sparfloxacin, temafloxacin, clarithromycin, and older agentsE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|April 1, 1985
Comparative activity of the quinolones against anaerobic bacteria isolated at community hospitalsE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|February 1, 1985
Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitalsE J Goldstein, D M Citron
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
How far should a clinical laboratory go in identifying anaerobic isolates, and who should pay?D M Citron, P C Appelbaum
Antimicrobial Agents and Chemotherapy|October 23, 1997
Comparative in vitro activities of trovafloxacin (CP-99,219) against 221 aerobic and 217 anaerobic bacteria isolated from patients with intra-abdominal infectionsD M Citron, M D Appleman
Journal of Clinical Microbiology|November 1, 1988
Annual incidence, epidemiology, and comparative in vitro susceptibilities to cefoxitin, cefotetan, cefmetazole, and ceftizoxime of recent community-acquired isolates of the Bacteroides fragilis groupE J Goldstein, D M Citron
Antimicrobial Agents and Chemotherapy|December 20, 2000
Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteriaD M Citron, M D Appleman
Pageof 59